HOB Biotech Group Corp Ltd (688656) - Total Liabilities

Latest as of March 2026: CN¥86.13 Million CNY ≈ $12.60 Million USD

Based on the latest financial reports, HOB Biotech Group Corp Ltd (688656) has total liabilities worth CN¥86.13 Million CNY (≈ $12.60 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore HOB Biotech Group Corp Ltd annual equity growth to track the company's year-over-year net asset growth rate.

HOB Biotech Group Corp Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how HOB Biotech Group Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688656 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

HOB Biotech Group Corp Ltd Competitors by Total Liabilities

The table below lists competitors of HOB Biotech Group Corp Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Anhui Estone Materials Technology Co Ltd SHG:688733	China	CN¥1.29 Billion
Huachangda Intelligent Equipment Group Co Ltd SHE:300278	China	CN¥1.82 Billion
AP (Thailand) Public Company Limited BK:AP	Thailand	฿39.58 Billion
Maccura Biotechnology Co Ltd SHE:300463	China	CN¥1.68 Billion
Bank Sinarmas Tbk JK:BSIM	Indonesia	Rp40.60 Trillion
Luoxin Pharmaceuticals Group Stock Co Ltd SHE:002793	China	CN¥2.39 Billion
Shenzhen Centralcon Investment Holding Co Ltd SHE:000042	China	CN¥31.91 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down HOB Biotech Group Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HOB Biotech Group Corp Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.09	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how HOB Biotech Group Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for HOB Biotech Group Corp Ltd (2016–2025)

The table below shows the annual total liabilities of HOB Biotech Group Corp Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥111.30 Million ≈ $16.29 Million	-49.56%
2024-12-31	CN¥220.67 Million ≈ $32.29 Million	+59.30%
2023-12-31	CN¥138.52 Million ≈ $20.27 Million	-16.04%
2022-12-31	CN¥164.99 Million ≈ $24.14 Million	+75.67%
2021-12-31	CN¥93.92 Million ≈ $13.74 Million	+4.33%
2020-12-31	CN¥90.02 Million ≈ $13.17 Million	-32.59%
2019-12-31	CN¥133.54 Million ≈ $19.54 Million	+44.99%
2018-12-31	CN¥92.10 Million ≈ $13.48 Million	+41.27%
2017-12-31	CN¥65.20 Million ≈ $9.54 Million	-4.04%
2016-12-31	CN¥67.94 Million ≈ $9.94 Million	--

About HOB Biotech Group Corp Ltd

SHG:688656 China Medical Devices

Market Cap

$808.92 Million

CN¥5.53 Billion CNY

Market Cap Rank

#9816 Global

#2518 in China

Share Price

CN¥87.03

Change (1 day)

+1.87%

52-Week Range

CN¥78.49 - CN¥213.11

All Time High

CN¥213.11